Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aptatek BioSciences has developed PheCheck, an FDA Breakthrough Device-designated, handheld, smartphone-enabled, DNA aptamer-based in‑home monitoring system that quantitatively measures blood phenylalanine from a fingerstick for phenylketonuria patients; clinical feasibility studies and initial evaluations show quantitative performance comparable to laboratory gold standards (HPLC, mass spectrometry) and support ongoing clinical development toward commercialization.[1][3][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aptatek BioSciences.